Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: The CNTRICS initiative

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 9, 2013, Pages 2166-2180

  Millan, Mark J ^a   Bales, Karen L ^b  

^a Unit for Research and Discovery in Neuroscience   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Affective behaviour; Antipsychotic; Emotion; Eye tracking; Gaze; Mouse; Negative symptoms; Non human primate; Oxytocin; Psychosis; Rat; Sociability; Social recognition

Indexed keywords

OXYTOCIN;

COGNITIVE DEFECT; CULTURAL FACTOR; DELUSION; EMOTIONALITY; EYE TRACKING; FUNCTIONAL ASSESSMENT; GAZE; HUMAN; MENTAL HEALTH; MOTIVATION; NEGATIVE SYNDROME; NEUROPHARMACOLOGY; NONHUMAN; PARANOIA; POSITIVE SYNDROME; PRIMATE; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL COGNITION; SOCIAL INTERACTION; VERBALIZATION; VOLE;

AFFECTIVE BEHAVIOUR; ANTIPSYCHOTIC; EMOTION; EYE-TRACKING; GAZE; MOUSE; NEGATIVE SYMPTOMS; NON-HUMAN PRIMATE; OXYTOCIN; PSYCHOSIS; RAT; SOCIABILITY; SOCIAL RECOGNITION;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 84888824726     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.09.012     Document Type: Review

References (214)

1. Addington J., Penn D.L., Woods S.W., Addington D., Perkins D. Facial affect recognition in individuals at clinical high risk for psychosis. British Journal of Psychiatry 2013, (in press).
2. Adolphs R. The social brain: neural basis of social knowledge. Annual Review of Psychology 2009, 60:693-716.
3. Ahern T.H., Modi M.E., Burkett J.P., Young L.J. Evaluation of two automated metrics for analyzing partner preference tests. Journal of Neuroscience Methods 2009, 182:180-188.
4. Amodio D.M., Frith C.D. Meeting of minds: the medial frontal cortex and social cognition. Nature Reviews Neuroscience 2006, 7:268-277.
5. Ando K., Johanson C.E., Levy D.L., Yasillo N.J., Holzman P.S., Schuster C.R. Effects of phencyclidine, secobarbital and diazepam on eye tracking in rhesus monkeys. Psychopharmacology 1983, 81:295-300.
6. Ando K., Johanson C.E., Schuster C.R. Effects of dopaminergic agents on eye tracking before and after repeated methamphetamine. Pharmacology, Biochemistry and Behavior 1986, 24:693-699.
7. Bachevalier J., Málková L. The amygdala and development of social cognition: theoretical comment on Bauman, Toscano, Mason, Lavenex, and Amaral. Behavioral Neuroscience 2006, 120:989-991.
8. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Mendoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biological Psychiatry 2013, 74:180-188.
9. Barbato M., Liu L., Penn D.L., Keefe R.S.E., Perkins D.O., Woods S.W., Addington J. Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. Schizophrenia Research 2013, (in press).
10. Barch D.M., Carter C.S., CNTRICS Executive Committee Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative. Schizophrenia Bulletin 2008, 34:613-618.
11. Barch D.M., Dowd E.C. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bulletin 2010, 36:919-934.
12. Barrett L., Henzi P., Rendall D. Social brains, simple minds: does social complexity really require cognitive complexity?. Philosophical Transactions of the Royal Society of London B 2007, 362:561-575.
13. Bauman M.D., Toscano J.E., Mason W.A., Lavenex P., Amaral D.G. The expression of social dominance following neonatal lesions of the amygdala or hippocampus in rhesus monkeys (Macaca mulatta). Behavioral Neuroscience 2006, 120:749-760.
14. Bégou M., Volle J., Bertrand J.B., Brun P., Job D., Schweitzer A., Saoud M., D'Amato T., Andrieux A., Suaud-Chagny M.F. The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Neuroscience 2008, 157:29-39.
15. Ben-Ami Bartal I., Decety J., Mason P. Empathy and pro-social behavior in rats. Science 2011, 334:1427-1430.
16. Bielsky I.F., Hu S.B., Ren X., Terwilliger E.F., Young L.J. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 2005, 47:503-513.
17. Bielsky I.F., Young L.J. Oxytocin, vasopressin, and social recognition in mammals. Peptides 2004, 25:1565-1574.
18. Bora E., Pantelis C. Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis. Schizophrenia Research 2013, 144:31-36.
19. Boulay D., Pichat P., Dargazanli G., Estenne-Bouhtou G., Terranova J.P., Rogacki N., Stemmelin J., Coste A., Lanneau C., Desvignes C., Cohen C., Alonso R., Vigé X., Biton B., Steinberg R., Sevrin M., Oury-Donat F., George P., Bergis O., Griebel G., Avenet P., Scatton B. Characterization of SSR 103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacology, Biochemistry and Behavior 2008, 91:47-58.
20. Brown R.E., Singh P.B., Roser B. The major histocompatibility complex and the chemosensory recognition of individuality in rats. Physiology and Behavior 1987, 40:65-73.
21. Brüne M. Theory of mind in schizophrenia: a review of the literature. Schizophrenia Bulletin 2005, 31:21-42.
22. Buchanan R.W., Keefe R.S., Umbricht D., Green M.F., Laughren T., Marder S.R. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?. Schizophrenia Bulletin 2010, 37:1209-1217.
23. Burbridge J.A., Barch D.M. Anhedonia and the experience of emotion in individuals with schizophrenia. Journal of Abnormal Psychology 2007, 116:30-42.
24. Calcagnoli F., de Boer S.F., Althaus M., den Boer J.A., Koolhaas J.M. Antiaggressive activity of central oxytocin in male rats. Psychopharmacology 2013, 229:639-651.
25. Call J., Tomasello M. Does the chimpanzee have a theory of mind? 30 years later. Trends in Cognitive Science 2008, 12:187-192.
26. Carlier P., Jamon M. Observational learning in C57BL/6j mice. Behavioral Brain Research 2006, 174:125-131.
27. Carter C.S., Barch D.M. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophrenia Bulletin 2007, 33. 1131-1117.
28. Carter C.S., Barch D.M., Gur R., Gur R., Pinkham A., Ochsner K. CNTRICS final task selection: social cognitive and affective neuroscience-based measures. Schizophrenia Bulletin 2009, 35:153-162.
29. Carter C.S., Barch D.M., Buchanan R.W., Bullmore E., Krystal J.H., Cohen J., Geyer M., Green M., Nuechterlein K.H., Robbins T., Silverstein S., Smith E.E., Strauss M., Wykes T., Heinssen R. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biological Psychiatry 2008, 64:4-10.
30. Carter C.S., DeVries A.C., Getz L.L. Physiological substrates of mammalian monogamy: the prairie vole model. Neuroscience and Biobehavioral Reviews 1995, 19:303-314.
31. Cattaneo L., Rizzolatti G. The mirror neuron system. Archives of Neurology 2009, 66:557-560.
32. Choleris E., Clipperton-Allen A.E., Phan A., Kavaliers M. Neuroendocrinology of social information processing in rats and mice. Frontiers in Neuroendocrinology 2009, 30:442-459.
33. Clifton N.E., Morisot N., Girardon S., Millan M.J., Loiseau F. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine. Psychopharmacology 2013, 225:579-594.
34. Colonnello V., Iacobucci P., Fuchs T., Newberry R.C., Panksepp J. Octodon degus. A useful animal model for social-affective neuroscience research: basic description of separation distress, social attachments and play. Neuroscience and Biobehavioral Reviews 2011, 35:1854-1863.
35. Condy C., Wattiez N., Rivaud-Péchoux S., Gaymard B. Ketamine-induced distractibility: an oculomotor study in monkeys. Biological Psychiatry 2005, 57:366-372.
36. Connor R.C. Cooperation beyond the dyad: on simple models and a complex society. Philosophical Transactions of the Royal Society of London B 2010, 365:2687-2697.
37. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., David S.B., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 2011, 41:251-261.
38. Couture S.M., Penn D.L., Roberts D.L. The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 2006, 32:44-63.
39. Crawley J.N. What's Wrong with My Mouse?. Behavioral Phenotyping of Transgenic and Knockout Mice 2000, Wiley-Liss, Inc., New York.
40. Crawley J.N., Chen T., Puri A., Washburn R., Sullivan T.L., Hill J.M., Young N.B., Nadler J.J., Moy S.S., Young L.J., Caldwell H.K., Young W.S. Approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides 2007, 41:145-163.
41. Darke H., Peterman J.S., Park S., Sundram S., Carter O. Are patients with schizophrenia impaired in processing non-emotional features of human faces?. Frontiers in Psychology 2013, 20(4):529.
42. Davis M.C., Lee J., Horan W.P., Clarke A.D., McGee M.R., Green M.F., Marder S.R. Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophrenia Research 2013, 147:393-397.
43. de Bruin N.M., Prickaerts J., Lange J.H., Akkerman S., Andriambeloson E., de Haan M., Wijnen J., van Drimmelen M., Hissink E., Heijink L., Kruse C.G. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents. Neurobiology of Learning and Memory 2010, 93:522-531.
44. De Jaegher H., Di Paolo E., Gallagher S. Can social interaction constitute social cognition?. Trends in Cognitive Science 2010, 14:441-447.
45. Derntl B., Habel U. Deficits in social cognition: a marker for psychiatric disorders?. European Archives of Psychiatry and Clinical Neuroscience 2011, 261:S145-S149.
46. DeVries A.C., Carter C.S. Sex differences in temporal parameters of partner preference in prairie voles (Microtus ochrogaster). Canadian Journal of Zoology 1999, 77:885-889.
47. Domes G., Steiner A., Porges S.W., Heinrichs M. Oxytocin differentially modulates eye gaze to naturalistic social signals of happiness and anger. Psychoneuroendocrinology 2013, 38:1198-1202.
48. Dunbar R.I. The social role of touch in humans and primates: behavioural function and neurobiological mechanisms. Neuroscience and Biobehavioral Reviews 2010, 34:260-268.
49. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., Snouwaert J.N., Koller B.H. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behavioral Brain Research 2004, 153:507-519.
50. Eack S.M., Bahorik A.L., McKnight S.A., Hogarty S.S., Greenwald D.P., Newhill C.E., Phillips M.L., Keshavan M.S., Minshew N.J. Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophrenia Research 2013, 148:24-28.
51. Ebitz R.B., Watson K.K., Platt M.L. Oxytocin blunts social vigilance in the rhesus macaque. Proceedings of the National Academy of Sciences USA 2013, 110:11630-11635.
52. Emery N.J., Clayton N.S. Comparative social cognition. Annual Review of Psychology 2009, 60:87-113.
53. Engelmann M., Wotjak C.T., Landgraf R. Social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats. Physiology and Behavior 1995, 58:315-321.
54. Ey E., Yang M., Katz A.M., Woldeyohannes L., Silverman J.L., Leblond C.S., Faure P., Torquet N., Le Sourd A.M., Bourgeron T., Crawley J.N. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes, Brain and Behavior 2012, (in press).
55. Fairhall S.J., Dickson C.A., Scott L., Pearce P.C. A non-invasive method for studying an index of pupil diameter and visual performance in the rhesus monkey. Journal of Medical Primatology 2006, 35:67-77.
56. Fanning J.R., Bell M.D., Fiszdon J.M. Is it possible to have impaired neurocognition but good social cognition in schizophrenia?. Schizophrenia Research 2012, 135:68-71.
57. Fett A.K.J., Viechtbauer W., Dominguez M., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neuroscience and Biobehavioral Reviews 2011, 35:573-588.
58. Feifel D., Macdonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry W., Lefebvre M., Gonzales J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biological Psychiatry 2010, 68:678-680.
59. Feifel D., Mexal S., Melendez G., Liu P.Y., Goldenberg J.R., Shilling P.D. The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog. Neuropsychopharmacology 2009, 34:2011-2028.
60. Ferguson J.N., Young L.J., Insel T.R. The neuroendocrine basis of social recognition. Frontiers in Neuroendocrinology 2002, 23:200-224.
61. File S.E., Hyde J.R.G. Can social interaction be used to measure anxiety?. British Journal of Pharmacology 1978, 62:19-24.
62. File S.E., Seth P. A review of 25 years of the social interaction test. European Journal of Pharmacology 2003, 463:35-53.
63. Fischer-Shofty M., Brüne M., Ebert A., Shefet D., Levkovitz Y., Shamay-Tsoory S.G. Improving social perception in schizophrenia: the role of oxytocin. Schizophrenia Research 2013, 146:357-362.
64. Fischer-Shofty M., Shamay-Tsoory S.G., Levkovitz Y. Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls. Frontiers in Neuroscience 2013, 7:127.
65. Fitch W.T., Huber L., Bugnyar T. Social cognition and the evolution of language: constructing cognitive phylogenies. Neuron 2010, 65:795-814.
66. Foussias G., Agid O., Fervaha G., Remington G. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. European Neuropsychopharmacology 2013, (in press).
67. Fuentes A. Re-evaluating primate monogamy. American Anthropologist 1999, 100:890-907.
68. Fusar-Poli P., Placentino A., Carletti F., Landi P., Allen P., Surguladze S., Benedetti F., Abbamonte M., Gasparotti R., Barale F., Perez J., McGuire P., Politi P. Functional atlas of emotional faces processing a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. Journal of Psychiatry and Neuroscience 2009, 34:418-432.
69. Gabor C.S., Phan A., Clipperton-Allen A.E., Kavaliers M., Choleris E. Interplay of oxytocin, vasopressin, and sex hormones in the regulation of social recognition. Behavioral Neuroscience 2012, 126:97-109.
70. Galderisi S., Davidson M., Kahn R.S., Mucci A., Boter H., Gheorghe M.D., Rybakowski J.K., Libiger J., Dolifus S., Lopez-Ibor J.J., Peuskens J., Hranov L.G., Fleischhacker W.W., EUFEST Group Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophrenia Research 2008, 115:104-114.
71. Gao X.M., Elmer G.I., Adams-Huet B., Tamminga C.A. Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs. Pharmacology Biochemistry and Behaviour 2009, 92:236-242.
72. Gard D.E., Fisher M., Garrett C., Genevsky A., Vinogradov S. Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia. Schizophrenia Research 2008, 115:74-81.
73. Gibboni R.R., Zimmerman P.E., Gothard K.M. Individual differences in scanpaths correspond with serotonin transporter genotype and behavioral phenotype in rhesus monkeys (Macaca mulatta). Frontiers in Behavioral Neuroscience 2009, 3:1-11.
74. Goldman M.B., Gomes A.M., Carter C.S., Lee R. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology 2011, 216:101-110.
75. Gonzalez-Liencres C., Shamay-Tsoory S.G., Brune M. Toward a neuroscience of empathy: ontogeny, phylogeny, brain mechanisms, context, and psychopathology. Neuroscience and Biobehavioral Reviews 2013, 37:1537-1548.
76. Goodson J.L., Thompson R.R. Nonapeptide mechanisms of social cognition, behavior and species-specific social systems. Current Opinion in Neurobiology 2010, 20:784-794.
77. Green M.F., Bearden E., Cannon T.D., Fiske A.P., Helleman G.S., Horan W.P., Kee K., Kern R.S., Lee J., Sergi M.J., Subotnik K.L., Sugar C.A., Ventura J., Yee C.M., Nuechterlein K.H. Social cognition in schizophrenia. Part I: performance across phase of illness. Schizophrenia Bulletin 2011, 38:854-864.
78. Green M.F., Penn D.L., Bentall R., Carpenter W.T., Gaebel W., Gur R.C., Kring A.M., Park S., Silverstien S.M., Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin 2008, 34:1211-1220.
79. Grippo A.J., Johnson A.K. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21.
80. Guastella A.J., Mitchell P.B., Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biology Psychiatry 2008, 63:3-5.
81. Haker H., Kawohl W., Herwig U., Rössler W. Mirror neuron activity during contagious yawning - an fMRI study. Brain Imaging and Behavior 2013, 7:28-34.
82. Harich S., Gross G., Bespalov A. Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology 2007, 192:511-519.
83. Hart B.L., Hart L.A., Pinter-Wollman N. Large brains and cognition: where do elephants fit in?. Neuroscience and Biobehavioral Reviews 2008, 32:86-98.
84. Hennessy M.B., Mendoza S.P., Mason W.A., Moberg G.P. Endocrine sensitivity to novelty in squirrel monkeys and titi monkeys: species differences in characteristic modes of responding to the environment. Physiology and Behaviour 1995, 57:331-338.
85. Hermann E., Call J., Hernandez-Lloreda M.V., Hare B., Tomasello M. Humans have evolved specialized skills to social cognition: the cultural intelligence hypothesis. Science 2007, 317:1360.
86. Hida H., Mouri A., Noda Y. Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors. Journal of Pharmacological Sciences 2013, 121:185-191.
87. Hill S.K., Reilly J.L., Harris M.S.H., Khine T., Sweeney J.A. Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia. Schizophrenia Bulletin 2008, 34:494-506.
88. Holzman P.S., Levy D.L., Uhlenhuth E.H., Proctor L.R., Freedman D.X. Smooth pursuit eye movements, and diazepam, CPZ, and secobarbitol. Psychopharmacologia 1975, 44:112-115.
89. Horan W.P., Green M.F., DeGroot M., Fiske A., Helleman G., Kee K., et al. Social cognition in schizophrenia. Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin 2012, 38:865-872.
90. Ibi D., Nagai T., Koike H., Kitahara Y., Mizoguchi H., Niwa M., Jaaro-Peled H., Nitta A., Yoneda Y., Nabeshima T., Sawa A., Yamada K. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behavioral Brain Research 2010, 206:32-37.
91. Ishai A., Schmidt C.F., Boesiger P. Face perception is mediated by a distributed cortical network. Brain Research Bulletin 2005, 67:87-93.
92. Jarcho M.R., Mendoza S.P., Mason W.A., Yang X., Bales K.L. Intranasal vasopressin affects pair bonding and peripheral gene expression in male Callicebus cupreus. Genes, Brain and Behavior 2011, 10:375-383.
93. Kaidanovich-Beilin O., Lipina T., Vukobradovic I., Roder J., Woodgett J.R. Assessment of social interaction behaviors. Journal of Visual Experimentation. 2011, 25:48.
94. Kalkstein S., Hurford I., Gur R.C. Neurocognition in schizophrenia. Current Topics in Behavioural Neurosciences 2010, 4:373-390.
95. Keefe R.S., Fox K.H., Harvey P.D., Cucchiaro J., Siu C., Loebel A. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophrenia Research 2011, 125:161-168.
96. Kent K., Arientyl V., Khachatryan M.M., Wood R.I. Oxytocin induces a conditioned social preference in female mice. Journal of Neuroendocrinology 2013, 25:803-810.
97. Kerr J.N., Nimmerjahn A. Functional imaging in freely moving animals. Current Opinion in Neurobiology 2012, 22:45-53.
98. Klatt J.D., Goodson J.L. Oxytocin-like receptors mediate pair bonding in a socially monogamous songbird. Proceedings in Biology and Science 2013, 7:280.
99. Knapska E., Mikosz M., Werka T., Maren S. Social modulation of learning in rats. Learning Memory 2009, 17:35-42.
100. Knobbout D.A., Ellenbroek B.A., Cools A.R. The influence of social structure on social isolation in amphetamine-treated Java monkeys (Macaca fascicularis). Behavioral Pharmacology 1996, 7:417-429.
101. Koros E., Rosenbrock H., Birk G., Weiss C., Sams-Dodd F. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Neuropsychopharmacology 2007, 32:562-576.
102. Kring A.M., Moran E.K. Emotional response deficits in schizophrenia: insights from affective science. Schizophrenia Bulletin 2008, 34:819-834.
103. Langford D.J., Crager S.E., Shehzad Z., Smith S.B., Sotocinal S.G., Levenstadt J.S., Chanda M.L., Levitin D.J., Mogil J.S. Social modulation of pain as evidence for empathy in mice. Science 2006, 312:1967-1970.
104. Lee A.G., Cool D.R., Grunwald W.C., Neal D.E., Buckmaster C.L., Cheng M.Y., Hyde S.A., Lyons D.M., Parker K.J. A novel form of oxytocin in New World monkeys. Biology Letters 2011, 7:584-587.
105. Levy D.L., Sereno A.B., Gooding D.C., O'Driscoll G.A. Eye tracking dysfunction in schizophrenia: characterization and pathophysiology. Current Topics in Behavioral Neuroscience 2010, 4:311-347.
106. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lönnqvist J., Huttunen M.O., Kaprio J., Trachtenberg J.T., Silva A.J., Cannon T.D. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proceedings of the National Academy of Science USA 2007, 104:18280-18285.
107. Lim M.M., Hammock E.A.D., Young L.J. The role of vasopressin in the genetic and neural regulation of monogamy. Journal of Neuroendocrinology 2004, 16:325-332.
108. Lipina T.V., Fletcher P.J., Lee F.H., Wong A.H., Roder J.C. Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology 2013, 38:423-436.
109. Liu J.C., Guastella A.J., Dadds M.R. Exploring the role of intra-nasal oxytocin on the partner preference effect in humans. Psychoneuroendocrinology 2013, 38:587-591.
110. 6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology 2008, 196:93-104.
111. 2) antagonists. European Neuropsychopharmacology 2009, 19:23-33.
112. Luck S.J., Ford J.M., Sarter M., Lustig C. CNTRICS final biomarker selection: control of attention. Schizophrenia Bulletin 2012, 38:53-61.
113. Machado C.J., Bliss-Moreau E., Platt M.L., Amaral D.G. Social and nonsocial content differentially modulates visual attention and autonomic arousal in Rhesus macaques. PLoS One 2011, 6:e26598.
114. Machado C.J., Nelson E.E. Eye-tracking with nonhuman primates is now more accessible than ever before. American Journal of Primatology 2011, 73:562-569.
115. Marino L. Convergence of complex cognitive abilities in cetaceans and primates. Brain, Behavior and Evolution 2002, 59:21-32.
116. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain, Behavior and Immunity 2008, 22:806-816.
117. Mathiasen J.R., DiCamillo A. Social recognition assay in the rat. Current Protocols in Neuroscience 2010, 8:8.5I.
118. McGraw L.A., Young L.J. The prairie vole: an emerging model organism for understanding the social brain. Trends in Neuroscience 2009, 33:106-109.
119. Meffre J., Chaumont-Dubel S., Mannoury la Cour C., Loiseau F., Watson D.J., Dekeyne A., Séveno M., Rivet J.-M., Gaven F., Déléris P., Hervé D., Fone K.C., Bockaert J., Millan M.J., Marin P. 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Molecular Medicine 2012, 4:1043-1056.
120. Melloni M., Lopez V., Ibanez A. Empathy and contextual social cognition. Cognitive Affective Behavioral Neuroscience 2013, (in press).
121. Meyer-Lindenberg A., Domes G., Kirsch P., Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nature Review Neuroscience 2011, 12:524-538.
122. Millan M.J. The neurobiology and control of anxious states. Progress in Neurobiology 2013, 70:83-244.
123. Millan M.J., Agid Y., Brüne M., Bullmore E.T., Carter C.S., Clayton N.S., Connor R., Davis S., Deakin B., DeRubeis R.J., Dubois B., Geyer M.A., Goodwin G.M., Gorwood P., Jay T.M., Joëls M., Mansuy I.M., Meyer-Lindenberg A., Murphy D., Rolls E., Saletu B., Spedding M., Sweeney J., Whittington M., Young L.J. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews in Drug Discovery 2012, 11:141-168.
124. Millan M.J., Brocco M. Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3)>D(2) antagonist, S33138. Therapie 2008, 63:187-229.
125. Millan M.J., Di Cara B., Dekeyne A., Panayi F., De Groote L., Sicard D., Cistarelli L., Billiras R., Gobert A. Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. Journal Pharmacology and Experimental Therapeutics 2007, 100:1047-1061.
126. Millan M.J., Gobert A., Roux S., Porsolt R., Meneses A., Carli M., Di Cara B., Jaffard R., Rivet J.M., Lestage P., Mocaer E., Peglion J.L., Dekeyne A. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis. Journal of Pharmacology and Experimental Therapeutics 2004, 311:190-203.
127. Miller M.L., Gallup A.C., Vogel A.R., Vicario S.M., Clark A.B. Evidence for contagious behaviors in budgerigars (Melopsittacus undulatus): an observational study of yawning and stretching. Behavior Processes 2012, 89:264-270.
128. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., Crawley J.N. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behavioural Brain Research 2007, 176:4-20.
129. Murray G.K., Clark L., Corlett P.R., Blackwell A.D., Cools R., Jones P.B., Robbins T.W., Poustka L. Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 2008, 8:34.
130. Nakagami E., Hoe M., Brekke J.S. The prospective relationship among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia. Schizophrenia Bulletin 2010, 36:935-948.
131. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 2004, 72:29-39.
132. Newsome W.T., Pare E.B. A selective impairment of motion perception following lesions of the middle temporal visual area (MT). The Journal of Neuroscience 1988, 8:2201-2211.
133. Newsome W.T., Wurtz R.H., Dursteler M.R., Mikami A. Deficits in visual motion processing following ibotenic acid lesions of the middle temporal visual area of the macaque monkey. The Journal of Neuroscience 1985, 5:825-840.
134. Newsome W.T., Wurtz R.H., Komatsu H. Relation of cortical areas MT and MST to pursuit eye movements. II. Differentiation of retinal from extraretinal inputs. Journal of Neurophysiology 1988, 60:604-620.
135. Noudoost B., Moore T. Control of visual cortical signals by prefrontal dopamine. Nature 2011, 474:375-379.
136. Ochsner K.N. The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond. Biological Psychiatry 2008, 64:48-61.
137. Oeltermann A., Ku S.-P., Logothetis N.K. A novel functional magnetic resonance imaging compatible search-coil eye-tracking system. Magnetic Resonance Imaging 2007, 25:913-922.
138. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., Harvey R., Waddington J.L. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147:18-27.
139. Palagi E., Leone A., Mancini G., Ferrari P.F. Contagious yawning in gelada baboons as a possible expression of empathy. Proceeding of the National Academy of Sciences USA 2009, 106:19262-19267.
140. Panksepp J.B., Lahvis G.P. Rodent empathy and affective neuroscience. Neuroscience and Biobehavioral Reviews 2011, 35:1864-1875.
141. Papaleo F., Lipska B.K., Weinberger D.R. Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 2012, 62:1204-1220.
142. Parr L.A., Modi M., Siebert E., Young L.J. Intranasal oxytocin selectively attenuates rhesus monkeys' attention to negative facial expressions. Psychoneuroendocrinology 2013, 8:1748-1756.
143. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., Leserman J., Jarskog L.F., Penn D.L. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophrenia Research 2011, 132:50-53.
144. Peleg-Raibstein D., Feldon J., Meyer U. Behavioural animal models of antipsychotic drug actions. Handbook of Experimental Pharmacology 2012, 212:361-406.
145. Penn D.L., Sanna L.J., Roberts D.L. Social cognition in schizophrenia: an overview. Schizophrenia Bulletin 2008, 34:408-411.
146. Perio A., Terranova J.P., Worms P., Bluthe R.M., Dantzer R., Biziere K. Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants. Psychopharmacology 1989, 97:262-268.
147. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biological Psychiatry 2003, 54:504-514.
148. Pijnenborg G.H.M., Withaar F.K., Evans J.J., Van den Bosch R.J., Timmerman M.E., Brouwer W.H. The predictive value of measures of social cognition for community functioning in schizophrenia: implications for neuropsychological assessment. Journal of the International Neuropsychology Society 2009, 15:239-247.
149. Pinkham A.E., Penn D.L., Green M.F., Buck B., Healey K., Harvey P.D. The social cognition psychometric evaluation study: results of the expert survey and RAND Panel. Schizophrenia Bulletin 2013, (in press).
150. Pinkham A.E., Penn D.L., Perkins D.O., Graham K., Siegel M. Emotion perception and the course of psychosis: a comparison of individuals at risk, and early and chronic schizophrenia spectrum illness. Cognitive Neuropsychiatry 2007, 12:198-212.
151. Plotnik J.M., Lair R., Suphachoksahakun W., de Waal F.B. Elephants know when they need a helping trunk. Proceedings National Academy of Sciences USA 2011, 108:5116-5121.
152. Popik P., Vetulani J., van Ree J.M. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology 1992, 106:71-74.
153. Pratt J., Winchester C., Dawson N., Morris B. Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nature Reviews Drug Discovery 2012, 11:560-579.
154. Premack D. Human and animal cognition: continuity and discontinuity. Proceeding of the National Academy of Sciences USA 2007, 104:13861-13867.
155. Reilly J.L., Lencer R., Bishop J., Keedy S., Sweeney J.A. Pharmacological studies of eye movement control. Brain and Cognition 2008, 68:415-432.
156. Rennie S.M., Moita M.M., Mainen Z.F. Social cognition in the rodent: nothing to be sniffed at. Trends in Cognitive Science 2013, 17:306-307.
157. Romero T., Konno A., Hasegawa T. Familiarity bias and physiological responses in contagious yawning by dogs support link to empathy. PLoS One 2013, 8:e71365.
158. Roullet F.I., Crawley J.N. Mouse models of autism: testing hypotheses about molecular mechanisms. Current Topics in Behavioral Neuroscience 2011, 7:187-212.
159. Rossi A.F., Pessoa L., Desimone R., Ungerleider L.G. The prefrontal cortex and the executive control of attention. Experimental Brain Research 2009, 192:489-497.
160. Rutte C., Taborsky M. Generalized reciprocity in rats. PLoS Biology 2007, 5:1421-1425.
161. Sams-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Review of Neuroscience 1999, 10:59-90.
162. Sams-Dodd F., Newman J.D. Effects of administration regime on the psychotomimetic properties of d-amphetamine in the squirrel monkey (Saimiri sciureus). Pharmacology Biochemistry and Behavior 1997, 56:471-480.
163. Sanna F., Argiolas A., Melis M.R. Oxytocin-induced yawning: sites of action in the brain and interaction with mesolimbic/mesocortical and incertohypothalamic dopaminergic neurons in male rats. Hormones and Behavior 2012, 62:505-514.
164. Scattoni M.L., Crawley J., Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodelopemental disorders. Neuroscience and Biobehavioural Reviews 2009, 33:508-515.
165. Scattoni M.L., Ricceri L., Crawley J.N. Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters. Genes, Brain and Behavior 2011, 10:44-56.
166. Schmidt S.J., Mueller D.R., Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophrenia Bulletin 2011, 37:S41-S54.
167. Schneeberger K., Dietz M., Taborsky M. Reciprocal cooperation between unrelated rats depends on cost to donor and benefit to recipient. BMC Evolution Biology 2012, 12:41.
168. Schneider M., Koch M. Deficient social and play behaviour in juvenile and adult rats after neonatal cortical lesions: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 2005, 30:944-957.
169. Schreiber R., Vivian J., Hedley L., Szczepanski K., Secchi R.L., Zuzow M., van Laarhoven S., Moreau J.L., Martin J.R., Sik A., Blokland A. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. European Neuropsychopharmacology 2007, 17:277-288.
170. Schwabe K., Klein S., Koch M. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Behavioural Brain Research 2006, 168:150-160.
171. Seillier A., Martinez A.A., Giuffrida A. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia. Neuropsychopharmacology 2006, 38:1816-1824.
172. Selemon L.D., Friedman H.R. Motor stereotypies and cognitive perseveration in non-human primates exposed to early gestational irradiation. Neuroscience 2013, 248:213-224.
173. Sergi M.J., Rassavosky Y., Widmark C., Reist C., Erhart S., Braff D.L., Marder S.R., Green M.F. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophrenia Research 2007, 90:316-324.
174. Shadlen M.N., Britten K.H., Newsome W.T., Movshon J.A. A computational analysis of the relationship between neuronal and behavioral responses to visual motion. The Journal of Neuroscience 1996, 16:1486-1510.
175. Shahrestani S., Kemp A.H., Guastella A.J. The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis. Neuropsychopharmacology 2013, 38:1929-1936.
176. Shepard K.N., Liu R.C. Experience restores innate female preference for male ultrasonic vocalizations. Genes, Brain, and Behavior 2011, 10:28-34.
177. Shepherd S.V., Platt M.L. Noninvasive telemetric gaze tracking in freely moving socially housed prosimian primates. Methods 2006, 38:185-194.
178. Shepherd S.V., Platt M.L. Spontaneous social orienting and gaze following in ringtailed lemurs (Lemur catta). Animal Cognition 2008, 11:13-20.
179. Shepherd S.V., Steckenfinger S.A., Hasson U., Ghazanfar A.A. Human-monkey gaze correlations reveal convergent and divergent patterns of movie viewing. Current Biology 2010, 20:649-656.
180. Siviy S.M., Panksepp J. In search of the neurobiological substrates for social playfulness in mammalian brains. Neuroscience and Biobehavioral Reviews 2011, 35:1821-1830.
181. Smith A.S., Agmo A., Birnie A.K., French J.A. Manipulation of the oxytocin system alters social behavior and attraction in pair-bonding primates, Callithrix penicillata. Hormones and Behavior 2010, 57:255-262.
182. Smith J.D. The study of animal metacognition. Trends in Cognitive Science 2009, 13:385-391.
183. Sprenger A., Trillenberg P., Nagel M., Sweeney J.A., Lencer R. Enhanced top-down control during pursuit eye tracking in schizophrenia. European Archives of Psychiatry and Clinical Neurosciences 2013, 263:223-231.
184. Stone W.S., Iguchi L. Do apparent overlaps between schizophrenia and autistic spectrum disorders reflect superficial similarities or etiological commonalities?. North American Journal of Medicine and Science 2011, 4:124-133.
185. Sundberg H., Doving K., Novikov S., Ursin H. A method for studying responses and habituation to odors in rats. Behavioral and Neural Biology 1982, 34:113-119.
186. Takao K., Kobayashi K., Hagihara H., Ohira K., Shoji H., Hattori S., Koshimizu H., Umemori J., Toyama K., Nakamura H.K., Kuroiwa M., Maeda J., Atsuzawa K., Esaki K., Yamaguchi S., Furuya S., Takagi T., Walton N.M., Hayashi N., Suzuki H., Higuchi M., Usuda N., Suhara T., Nishi A., Matsumoto M., Ishii S., Miyakawa T. Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 2013, 1409-1425.
187. Teng B.L., Nonneman R.J., Agster K.L., Nikolova V.D., Davis T.T., Riddick N.V., Baker L.K., Pedersen C.A., Jarstfer M.B., Moy S.S. Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology 2013, 72:187-196.
188. Terranova J.P., Chabot C., Barnouin M.C., Perrault G., Depoortere R., Griebel G., Scatton B. SSR 181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology 2005, 181:134-144.
189. Terranova J.P., Storme J.J., Lafon N., Pério A., Rinaldi-Carmona M., Le Fur G., Soubrié P. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 1996, 126:165-172.
190. Thompson A., Papas A., Bartholomeusz C., Allott K., Amminger G.P., Nelso B., Wood S., Yung A. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations. Schizophrenia Research 2012, 141:204-209.
191. Toh W.L., Rossell S.L., Castle D.J. Current visual scanpath research: a review of investigations into the psychotic, anxiety, and mood disorders. Comprehensive Psychiatry 2011, 52:567-579.
192. Tomasello M., Carpenter M., Call J., Behne T., Moll H. Understanding and sharing intentions: the origins of cultural cognition. Behavior Brain Science 2005, 28:675-691.
193. van der Staay F.J., Arndt S.S., Nordquist R.E. Evaluation of animal models of neurobehavioral disorders. Behavioural Brain Function 2009, 25:5-11.
194. van der Kooij M.A., Sandi C. Social memories in rodents: methods, mechanisms and modulation by stress. Neuroscience and Biobehavioral Reviews 2012, 36:1763-1772.
195. Van Hooren S., Versmissen D., Janssen I., Myin-Germeys I., à Campo J., Mengelers R., Van Os J., Krabbendam L. Social cognition and neurocognition as independent domains in psychosis. Schizophrenia Research 2008, 103:257-265.
196. Van Overwalle F., Baetens K. Understanding others' actions and goals by mirror and mentalizing systems: a meta-analysis. Neuroimage 2009, 48:564-584.
197. van Schaik C.P., Isler K., Burkart J.M. Explaining brain size variation: from social to cultural brain. Trends in Cognitive Science 2012, 16:277-284.
198. Vasconcelos M., Hollis K., Nowbahari E., Kacelnik A. Pro-sociality without empathy. Biological Letters 2012, 8:910-912.
199. Veenema A.H., Neumann I.D. Central vasopressin and oxytocin release: regulation of complex social behaviours. Progress in Brain Research 2008, 170:261-276.
200. Wacker D.W., Ludwig M. Vasopressin, oxytocin, and social odour recognition. Hormones and Behavior 2012, 61:259-265.
201. Watson D.J., Loiseau F., Ingallinesi M., Millan M.J., Marsden C.A., Fone K.C. Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology 2012, 37:770-786.
202. Watson K.K., Ghodasra J.H., Platt M.L. Serotonin transporter genotype modulates social reward and punishment in rhesus macaques. PLoS One 2009, 4:e4156.
203. Watson K.K., Platt M.L. Of mice and monkeys: using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. Journal Neurodevelopmental Disorders 2012, 4:21-28.
204. Williams J.R., Catania K.C., Carter C.S. Development of partner preferences in female prairie voles (Microtus ochrogaster): the role of social and sexual experience. Hormones and Behavior 1992, 26:339-349.
205. Wilson C., Koenig J.L. Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. European Neuropsychopharmacology 2013, (in press).
206. Winslow J.T., Insel T.R. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002, 36:221-229.
207. Wöhr M., Scattoni M.L. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments. Behavioral Brain Research 2013, 251:5-17.
208. Wöhr M., Schwarting R.K. Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation. Cell Tissue Research 2013, 354:81-97.
209. Yang M., Crawley J.N. Simple behavioral assessment of mouse olfaction. Current Protocols in Neuroscience 2009, 8. 8.24.
210. Yang M., Silverman J.L., Crawley J.N. Automated three-chambered social approach task for mice. Current Protocols in Neuroscience 2011, 8:8.26.
211. Yates J.R., Beckmann J.S., Meyer A.C., Bardo M.T. Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition. Drug Alcohol Dependence 2013, 129:240-246.
212. Yee C.M., Mathis K.I., Sun J.C., Sholty G.L., Lang P.J., Bachman P., Williams T.J., Bearden C.E., Cannon T.D., Green M.F., Subotnik K.L., Ventura J., Nuechterlein K.H. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. Journal of Abnormal Psychology 2010, 119:71-82.
213. Yorzinski J.L., Patricelli G.L., Babcock J.S., Pearson J.M., Platt M.L. Through their eyes: selective attention in peahens during courtship. Journal of Experimental Biology 2013, 216:3035-3046.
214. Young K.A., Gobrogge K.L., Liu Y., Wang Z.X. The neurobiology of pair-bonding: insights from a socially monogamous rodent. Frontiers in Neuroendocrinology 2010, 32:53-69.